One of GE HealthCare’s first moves after spinning out from under the General Electric umbrella earlier this year was to acquire Caption Health, a maker of artificial intelligence-powered ultrasound guidance technology.

今年早些时候，GE HealthCare从通用电气伞下旋转出来后的第一步就是收购Caption Health，这是一家由人工智能驱动的超声引导技术制造商。

The buyout is already paying off: GE HealthCare has now attracted a grant of more than $44 million from the Bill & Melinda Gates Foundation that’ll support the development of Caption’s AI algorithms, which help guide clinicians through the process of conducting an accurate ultrasound scan, whether or not they’ve received any formal training..

收购已经取得了回报：GE HealthCare现在已经从Bill＆Melinda Gates基金会吸引了超过4400万美元的赠款，该基金会将支持标题的AI算法的开发，这有助于指导临床医生完成准确的超声扫描过程，无论他们是否接受过任何正式培训。。

The foundation’s backing will specifically support Caption’s work to bring that technology to low- and middle-income countries, according to a Monday announcement. The AI will be integrated into a wide swath of ultrasound devices, including the less-expensive, easy-to-use handheld scanners that devicemakers like GE HealthCare are particularly focused on bringing to under-resourced communities..

根据星期一的公告，基金会的支持将特别支持Caption将该技术带到中低收入国家的工作。人工智能将被集成到各种各样的超声设备中，包括价格便宜，易于使用的手持扫描仪，这些扫描仪是GE HealthCare等设备制造商特别专注于为资源不足的社区带来的。。

The Gates-backed work will focus on improving maternal health and lung screening in these countries.

盖茨支持的工作将侧重于改善这些国家的孕产妇健康和肺部筛查。

According to data cited by GE HealthCare, the vast majority of all maternal deaths occur in low- and middle-income countries, but ultrasound scans can help reduce both maternal and child mortality by scanning for certain fetal health markers, umbilical blood flow, ectopic pregnancy and other conditions that may contribute to complications during pregnancy and delivery..

根据GE HealthCare引用的数据，绝大多数孕产妇死亡发生在低收入和中等收入国家，但超声扫描可通过扫描某些胎儿健康标志物，脐带血流量，异位妊娠来帮助降低孕产妇和儿童的死亡率和其他可能导致妊娠和分娩并发症的疾病。。

Maternal health was the core focus of the Gates Foundation’s annual Goalkeepers report, which was released earlier this month and singled out AI-assisted ultrasound as one of a handful of low-cost innovations that could potentially prevent thousands of maternal deaths and millions of stillbirths and infant deaths in poorer nations every year by 2040..

孕产妇健康是盖茨基金会年度守门员报告的核心焦点，该报告本月早些时候发布，并将人工智能辅助超声作为少数低成本创新之一，可能潜在地预防成千上万的孕产妇死亡和数百万死产到2040年，每年在较贫穷国家的婴儿死亡。。

Meanwhile, per GE HealthCare, a simple ultrasound scan of the lungs conducted at the point of care can help catch pneumonia in its earliest stages—and can also do so more accurately than an X-ray—therefore improving the chances of successfully treating the condition, which is the leading cause of death for children under the age of 5..

同时，根据GE HealthCare，在护理点进行的肺部简单超声扫描可以帮助在最早阶段捕获肺炎，并且还可以比X射线更准确地这样做-从而提高成功治疗该病的机会，这是5岁以下儿童死亡的主要原因。。

“Ultrasound is an essential tool for screening and diagnosis of various medical conditions, including the health of expectant mothers and managing respiratory diseases,” Roland Rott, president and CEO of the ultrasound business at GE HealthCare, said in the announcement.

GE HealthCare超声业务总裁兼首席执行官Roland Rott在公告中说：“超声是筛查和诊断各种医疗状况的重要工具，包括孕妇的健康和呼吸系统疾病的管理。”。

“However, a key limitation is the guidance of lesser-skilled users to effectively apply affordable point-of-care ultrasound in their care environment,” Rott continued. “This grant will help bring Caption Health’s leading AI technology customized to more users, and therefore contribute to increased access to higher-quality medical care.”.

Rott继续说：“然而，一个关键的限制是指导不太熟练的用户在他们的护理环境中有效地应用负担得起的护理点超声波。“这项拨款将有助于为更多用户定制Caption Health领先的AI技术，从而有助于增加获得更高质量医疗服务的机会。”。

Caption was previously the recipient of another Gates Foundation grant. Awarded in late 2020, amid one of the many peaks of the COVID-19 pandemic, the $4.95 million grant supported the company’s development of an AI algorithm for lung ultrasound scans to improve screening for potentially fatal respiratory diseases..

标题以前是另一个盖茨基金会资助的接受者。在2020年底颁发的COVID-19大流行的众多高峰之一中，495万美元的赠款支持该公司开发用于肺部超声扫描的AI算法，以改善对潜在致命呼吸系统疾病的筛查。。

That backing came shortly after Caption had earned FDA approval for its first AI tool, which helps clinicians perform heart ultrasounds to spot signs of cardiac disease.

在标题获得FDA批准其第一个AI工具后不久，该支持就出现了，该工具可帮助临床医生进行心脏超声检查以发现心脏病的迹象。